Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today October 23
August 01, 15:30
Boston Oncology and King Fahd Medical City (KFMC) Partner to Advance Localized Cell & Gene Therapy in Saudi Arabia
In a landmark initiative poised to transform healthcare in the Kingdom of Saudi Arabia, Boston Oncology and King Fahd Medical City (KFMC) have signed a Letter of Intent to collaborate on the localizat
August 01, 14:30
Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that it has entered into an o
August 01, 14:00
Takeda Announces First Quarter FY2024 Results - Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54099945&newsitemid=20240725145481&lan=en-US&anc
July 31, 11:40
Carestream Wins Renowned Award for Dental Films
We’re excited to announce Carestream recently received the Health Leaders Award in the Dental Category from Grupo Mídia in Brazil, a renowned international multimedia company. This distinguished aw
July 31, 10:45
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
Biogen Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.biogen.com&esheet=54101572&newsitemid=20240730216833&lan=en-US&anchor=Biogen+Inc.&index=1&md5=4c98be33119620eca3992544
July 30, 15:15
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal cance
July 30, 14:32
Galderma’s Relfydess™ (RelabotulinumtoxinA) Receives Positive Decision for Use in Europe
Galderma today announced that it has completed its European decentralized procedure (DCP), resulting in a positive decision for Relfydess™ (RelabotulinumtoxinA - previously referred to as QM1114). Rel
July 30, 11:45
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54098752&newsitemid=20240724837236&lan=en-US&anchor=Medidata&index=1&md5=67239cebded0696c115
July 28, 10:50
Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G GFAP assay for the fully automated, random-access LUMIPULSE® G immunoassay system
July 25, 17:25
Galderma Delivers Record Net Sales of 2.2 Billion USD and 10.8% Year-on-Year Growth at Constant Currency for the First Half of 2024
Galderma Group AG, the pure-play dermatology category leader, today announced its financial results for the first half of 2024. · Record net sales of 2.2 billion USD in the first half of 2024, with
July 25, 15:31
PHASE III ARCADIA 1 and 2 Trial Primary Results Published in The Lancet: Galderma’s Nemolizumab Improves Key Aspects of Atopic Dermatitis - Itch, Skin Lesions and Sleep Disturbance
Galderma today announced that full results from the phase III ARCADIA 1 and 2 clinical trials in atopic dermatitis were published in The Lancet (https://cts.businesswire.com/ct/CT?id=smartlink&url=htt
July 25, 14:30
Pearl Raises Largest-Ever Investment in Dental AI with $58 Million Round
Pearl (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhellopearl.com%2F%3Futm_campaign%3DPress%2520Releases%26utm_source%3Dlink&esheet=54098764&newsitemid=20240724200226&lan=en-US&a
July 25, 10:00
Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced that it has extended and expanded its manufacturing c
July 24, 13:45
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the opening of its flagship U.S. facility in Hopewell, N.J., at the Princeton West Innovation Campus,
July 21, 10:25
MicroVention Announces Settlement Against Former Employees for Trade Secret Misappropriation and Breach of Contract Among Other Claims
MicroVention, a fully owned subsidiary of Terumo Corporation, announced today that the United States District Court for the Central District of California has issued an injunction permanently enjoinin
July 19, 15:10
BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54096137&newsitemid=20240718157915&lan=en-US&anchor=BeiGene&index=1&md5=7fb29a782461d2203a45fc454af
July 19, 14:30
Hanyang University’s Digital Healthcare Center and MIT Media Lab Sign MOU to Jointly Develop Proposals for Research Collaborations
On July 8, Hanyang University’s Digital Healthcare Center signed a memorandum of understanding (MOU) with the Massachusetts Institute of Technology (MIT) Media Lab in Cambridge, Massachusetts, USA, to
July 19, 10:30
Brandnew Lab to Host Symposium on New Clinic-Use Ampoule ‘Nuvoen’
Brandnew Lab will be holding a symposium on July 22nd at the Brandnew Clinic in Cheongdam to introduce its new line of clinic-use ampoules, ‘NUVOEN’. At the symposium, Dr. Yoon Song Eun, the direct
July 17, 14:50
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline
SOTIO Biotech (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.sotio.com%2F&esheet=54094919&newsitemid=20240716652691&lan=en-US&anchor=SOTIO+Biotech&index=1&md5=279e5245d8e335ff5
July 12, 15:20
ILJIN SNT Co., Ltd. Calls on Board of Aurinia Pharmaceuticals to Honor Shareholders’ Voices Expressed at the AGM
ILJIN SNT Co., Ltd. (“ILJIN”), one of the largest shareholders of Aurinia Pharmaceuticals (NASDAQ: AUPH) (“Aurinia” or the “Company”), today issued an open letter to fellow shareholders. The full text
July 12, 11:30
Parse Biosciences Launches Certified Service Provider Program
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54093141&newsitemid=20240711445815&lan=en-US&anchor=Parse+Biosciences&index=1&md
July 11, 15:50
Viromed Medical AG Seeks Special Approval for Cold Plasma Device for the Prevention of Ventilator-Associated Pneumonia (VAP)
Viromed Medical AG (ISIN: DE000A3MQR65; “Viromed”) is launching a second pioneering study on the use of cold plasma for the prevention of ventilator-associated pneumonia (VAP). The study, under the sc
July 11, 11:41
Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
Merz Therapeutics announces today the successful acquisition of INBRIJA® (levodopa inhalation powder) and (F)AMPYRA® (fampridine), and related assets from Acorda Therapeutics, Inc. AMPYRA® (dalfamprid
July 10, 15:56
Brandnew Lab launches three ‘Nuvoen’ ampoule series for clinics
Brandnew Lab announced that it has launched three ampoule products - Boost, Lipo, and PLLA - under its clinic solution brand ‘Nuvoen’, which has the slogan ‘bring new vitality to the skin’, on July 10
July 10, 15:25
MMI Builds Global Momentum with Multiple Distribution Agreements and Regulatory Approvals
MMI (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.mmimicro.com%2F&esheet=54090621&newsitemid=20240709821670&lan=en-US&anchor=MMI&index=1&md5=df42141cdf355f8be68a32aeb0578189)
«
2
3
4
5
6
»
25 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice